Article Text

Download PDFPDF
Pharmacokinetics of a single intravenous dose of marbofloxacin in adult donkeys
  1. F. González, DVM, PhD1,
  2. C. Rodríguez, DVM, PhD1,
  3. J. J. De Lucas, DVM, PhD1,
  4. S. Waxman, DVM, PhD3,
  5. M. D. San Andrés, DVM, PhD1,
  6. C. Serres, DVM, PhD2,
  7. J. Nieto, DVM, PhD1 and
  8. M. I. San Andrés, DVM, PhD1
  1. 1 Cátedra de Farmacología
  2. 2 Departamento Patología Animal II, Facultad de Veterinaria, Universidad Complutense de Madrid, Avda/Puerto de Hierro s/n. 28040 Madrid, Spain
  3. 3 Cátedra de Farmacología, Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, Argentine


Six donkeys each received 2 mg/kg marbofloxacin as a 10 per cent aqueous solution administered intravenously. Principal pharmacokinetic parameters were determined and two efficacy indices were computed by using pharmacokinetic parameters and selected mic90 values of marbofloxacin against pathogenic equine strains to predict the efficacy of the drug at this dose. The pharmacokinetics of marbofloxacin in donkeys was characterised by a large mean volume of distribution at a steady state (1·15 [0·09] l/kg) and a long mean (sd) elimination half-life of 9·24 (1·96) hours. It was also characterised by a relatively slow total body clearance of 0·10 (0·02) l/kg/hour, slower than in horses. Using mic90 values of marbofloxacin against pathogenic equine strains with a daily dose of 2 mg/kg, appropriate values of efficacy indicators were obtained only for Enterobacteriaceae. Daily intravenous doses of 0·33, 2·62 and 20 mg/kg were calculated for evaluation in clinical trials of infections due to Enterobacteriaceae, Staphylococcus aureus and Streptococci, respectively.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.